PIK3CA and breast carcinoma: Instead, our findings of a prospective well-defined homogenous cohort of early-stage breast cancer patients provide new insights to the realistic frequency of PIK3CA-mutations overall and in subgroups, as well as their association with recurrence-free interval and overall survival.